Press & Media Info
Welcome to the MFPL press area
To subscribe to our press releases (see below), arrange interviews with our scientists and for further information please don't hesitate to contact our communications team. We will be happy to help.
For general information about MFPL and download material, the following pages might be helpful
About Us | Information Material | Contact
Communications
Lilly Sommer
Georg BauerPress Releases
1 million euro FFG funding to boost structural biology research
24.05.13
“Laura Bassi Centre of Excellence” of Kristina Djinovic-Carugo extended for another three yearsmore
Flu and bacteria: Better prognosis for this potentially fatal combination
25.04.13
Research by scientists from the Max F. Perutz Laboratories points to new treatment optionsmore
Tipping the balance of signaling pathways
28.02.13
Manuela Baccarini and her team at the Max F. Perutz Laboratories of the University of Vienna and the Medical University of Vienna have discovered a new mechanism that links and regulates two signaling pathways involved in cell...more
Immune biologist identifies new switch in immune response
24.01.13
Work by Pavel Kovarik and his team at the Max F. Perutz Laboratories of the University of Vienna and the Medical University of Vienna identified the protein CDK8 as a critical regulator of the body’s immune system. The study,...more
The Bacterial Ribosome at the Cutting Edge of Stress
27.09.11
New publication in CELL of MFPL group leader Isabella Moll reveals a novel mechanism of stress response in E. coli.more
The machinery for recombination is part of the chromosome structure
09.08.11
New CELL paper of Franz Kleinmore
ERC Starting Grants for Bojan Zagrovic and Alwin Köhler!
26.07.11
MFPL scientists have now received 4 ERC grants within a year.more
Alwin Köhler receives FWF START prize 2011!
21.06.11
The FWF awards the annual START prize to outstanding young researchers and supports promising projects with a long-term grant.more
New publication by the Kovarik group in PLOS Pathogens!
26.05.11
In the study, the scientists found that the human pathogen Streptococcus pyogenes induces type I interferon production which is needed for defense of mice against this pathogen. In animal models type I interferons are ...more
